PMC:1283364 / 4629-4834 JSONTXT

{"project":"craft-sa-dev","denotations":[{"id":"T1172","span":{"begin":36,"end":44},"obj":"VBN"},{"id":"T1175","span":{"begin":6,"end":14},"obj":"NN"},{"id":"T1179","span":{"begin":15,"end":21},"obj":"MD"},{"id":"T1180","span":{"begin":22,"end":24},"obj":"VB"},{"id":"T1181","span":{"begin":25,"end":35},"obj":"RB"},{"id":"T1182","span":{"begin":45,"end":47},"obj":"IN"},{"id":"T1183","span":{"begin":48,"end":54},"obj":"NN"},{"id":"T1184","span":{"begin":55,"end":61},"obj":"NNS"},{"id":"T1185","span":{"begin":62,"end":68},"obj":"IN"},{"id":"T1186","span":{"begin":88,"end":94},"obj":"VBN"},{"id":"T1187","span":{"begin":69,"end":74},"obj":"DT"},{"id":"T1188","span":{"begin":75,"end":83},"obj":"NNS"},{"id":"T1189","span":{"begin":84,"end":87},"obj":"VBP"},{"id":"T1190","span":{"begin":95,"end":97},"obj":"IN"},{"id":"T1191","span":{"begin":98,"end":106},"obj":"NNS"},{"id":"T1192","span":{"begin":106,"end":107},"obj":"."},{"id":"T1194","span":{"begin":108,"end":115},"obj":"RB"},{"id":"T1195","span":{"begin":185,"end":188},"obj":"VBP"},{"id":"T1196","span":{"begin":115,"end":117},"obj":","},{"id":"T1197","span":{"begin":117,"end":120},"obj":"DT"},{"id":"T1198","span":{"begin":140,"end":150},"obj":"NNS"},{"id":"T1199","span":{"begin":121,"end":129},"obj":"JJ"},{"id":"T1200","span":{"begin":130,"end":139},"obj":"NN"},{"id":"T1201","span":{"begin":151,"end":155},"obj":"RBS"},{"id":"T1202","span":{"begin":156,"end":162},"obj":"JJ"},{"id":"T1203","span":{"begin":163,"end":165},"obj":"TO"},{"id":"T1204","span":{"begin":166,"end":171},"obj":"VB"},{"id":"T1205","span":{"begin":172,"end":177},"obj":"JJ"},{"id":"T1206","span":{"begin":178,"end":184},"obj":"NNS"},{"id":"T1207","span":{"begin":189,"end":194},"obj":"RB"},{"id":"T1208","span":{"begin":195,"end":197},"obj":"IN"}],"relations":[{"id":"R769","pred":"nsubjpass","subj":"T1175","obj":"T1172"},{"id":"R773","pred":"aux","subj":"T1179","obj":"T1172"},{"id":"R774","pred":"auxpass","subj":"T1180","obj":"T1172"},{"id":"R775","pred":"advmod","subj":"T1181","obj":"T1172"},{"id":"R776","pred":"prep","subj":"T1182","obj":"T1172"},{"id":"R777","pred":"compound","subj":"T1183","obj":"T1184"},{"id":"R778","pred":"pobj","subj":"T1184","obj":"T1182"},{"id":"R779","pred":"mark","subj":"T1185","obj":"T1186"},{"id":"R780","pred":"advcl","subj":"T1186","obj":"T1172"},{"id":"R781","pred":"det","subj":"T1187","obj":"T1188"},{"id":"R782","pred":"nsubjpass","subj":"T1188","obj":"T1186"},{"id":"R783","pred":"auxpass","subj":"T1189","obj":"T1186"},{"id":"R784","pred":"prep","subj":"T1190","obj":"T1186"},{"id":"R785","pred":"pobj","subj":"T1191","obj":"T1190"},{"id":"R786","pred":"punct","subj":"T1192","obj":"T1172"},{"id":"R787","pred":"advmod","subj":"T1194","obj":"T1195"},{"id":"R788","pred":"punct","subj":"T1196","obj":"T1195"},{"id":"R789","pred":"det","subj":"T1197","obj":"T1198"},{"id":"R790","pred":"nsubj","subj":"T1198","obj":"T1195"},{"id":"R791","pred":"amod","subj":"T1199","obj":"T1198"},{"id":"R792","pred":"compound","subj":"T1200","obj":"T1198"},{"id":"R793","pred":"advmod","subj":"T1201","obj":"T1202"},{"id":"R794","pred":"amod","subj":"T1202","obj":"T1198"},{"id":"R795","pred":"aux","subj":"T1203","obj":"T1204"},{"id":"R796","pred":"xcomp","subj":"T1204","obj":"T1202"},{"id":"R797","pred":"amod","subj":"T1205","obj":"T1206"},{"id":"R798","pred":"dobj","subj":"T1206","obj":"T1204"},{"id":"R799","pred":"advmod","subj":"T1207","obj":"T1195"},{"id":"R800","pred":"prep","subj":"T1208","obj":"T1195"}],"text":"ering approach should be rigorously examined in animal models before these reagents are tested in patients. However, the chemical secretase inhibitors most likely to reach human trials are still in develop"}

{"project":"craft-ca-core-ex-dev","denotations":[{"id":"T682","span":{"begin":48,"end":54},"obj":"NCBITaxon:33208"},{"id":"T683","span":{"begin":75,"end":83},"obj":"CHEBI_EXT:33893"},{"id":"T684","span":{"begin":121,"end":129},"obj":"CHEBI_EXT:chemical_substance_or_polyatomic_entity"},{"id":"T685","span":{"begin":140,"end":150},"obj":"CHEBI_EXT:35222"},{"id":"T686","span":{"begin":172,"end":177},"obj":"NCBITaxon:9606"}],"text":"ering approach should be rigorously examined in animal models before these reagents are tested in patients. However, the chemical secretase inhibitors most likely to reach human trials are still in develop"}

{"project":"craft-ca-core-dev","denotations":[{"id":"T589","span":{"begin":48,"end":54},"obj":"NCBITaxon:33208"},{"id":"T590","span":{"begin":75,"end":83},"obj":"CHEBI:33893"},{"id":"T591","span":{"begin":140,"end":150},"obj":"CHEBI:35222"},{"id":"T592","span":{"begin":172,"end":177},"obj":"NCBITaxon:9606"}],"text":"ering approach should be rigorously examined in animal models before these reagents are tested in patients. However, the chemical secretase inhibitors most likely to reach human trials are still in develop"}